Skip to content

Perspective of cancer patient in COVID-19 pandemic

Perspective of cancer patient in COVID-19 pandemic: an obsevational study

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028438
Enrollment
1000
Registered
2020-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Ability to read, write, or comprehend spoken language will be a prerequisite for entry into this study. The questionnaire will be filled out by either the patient or a family member if the patient is unable to read.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they are in severe physical distress because of cancer or therapy- related complications, in altered sensorium, are not receiving any active systemic therapy and oral targeted therapy, has no evidence of disease recurrence or progression, are planned only for best supportive care, and are being considered an inpatient admission for supportive care.

Design outcomes

Primary

MeasureTime frame
The primary end point of study will be the proportion of patients who wish to continue or discontinue systemic therapy/ radiotherapy/ chemo-radiotherapy during the pandemic. Timepoint: 3 months

Secondary

MeasureTime frame
The primary end point of study will be the proportion of patients who wish to continue or discontinue systemic therapy/ radiotherapy/ chemo-radiotherapy during the pandemic. Timepoint: 3 months

Countries

India

Contacts

Public ContactShabnum Thakur

IGMC Shimla

thakurshabnum7@gmail.com9459830966

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026